Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04053452 · ClinicalTrials.gov registry record · NA
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04053452 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 20 participants.
The verdict
NCT04053452, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if peripheral nerve ultrasound can be used as a supplemental tool to diagnose Guillain-Barre syndrome (GBS) in the acute setting and aid in prognostication.
Interventions
- DIAGNOSTIC_TEST Peripheral nerve ultrasound
- DIAGNOSTIC_TEST Measurement of strength
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2024-02-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04053452
The ClinicalTrials.gov registry entry for NCT04053452 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peripheral nerve ultrasound is the first listed.
NCT04053452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04053452 about?
NCT04053452 is a clinical study titled "Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome". The purpose of this study is to determine if peripheral nerve ultrasound can be used as a supplemental tool to diagnose Guillain-Barre syndrome (GBS) in the acute setting and aid in prognostication.
What is the current status of trial NCT04053452?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2019-09-30. Estimated completion is 2024-02-05.
What interventions are being tested in trial NCT04053452?
The interventions under investigation include: Peripheral nerve ultrasound (DIAGNOSTIC_TEST), Measurement of strength (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04053452?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.